Amgen (AMGN) Offering Possible 25.94% Return Over the Next 17 Calendar Days

Amgen’s most recent trend suggests a bullish bias. One trading opportunity on Amgen is a Bull Put Spread using a strike $230.00 short put and a strike $225.00 long put offers a potential 25.94% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $230.00 by expiration. The full premium credit of $1.03 would be kept by the premium seller. The risk of $3.97 would be incurred if the stock dropped below the $225.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Amgen is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Amgen is bullish.

The RSI indicator is above 80 which suggests that the stock is in overbought territory.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Amgen

The Zacks Analyst Blog Highlights: Intercept, CymaBay, Amgen, Global Blood Therapeutics and ChemoCentryx
Fri, 29 Nov 2019 16:24:04 +0000
The Zacks Analyst Blog Highlights: Intercept, CymaBay, Amgen, Global Blood Therapeutics and ChemoCentryx

Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates
Fri, 29 Nov 2019 13:13:46 +0000
Biotech stocks had a fairly robust November, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) advancing over 10% for the month. This compares to the 3% gains for the S&P 500 Index. The month …

Were Hedge Funds Right About Warming Up To Amgen, Inc. (AMGN)?
Fri, 29 Nov 2019 03:33:16 +0000
We can judge whether Amgen, Inc. (NASDAQ:AMGN) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead into their best ideas. […]

Amgen (AMGN) Up 11.2% Since Last Earnings Report: Can It Continue?
Thu, 28 Nov 2019 14:31:02 +0000
Amgen (AMGN) reported earnings 30 days ago. What’s next for the stock? We take a look at earnings estimates for some clues.

Here’s Why Merck’s (MRK) Shares Are Up This Year
Thu, 28 Nov 2019 13:44:01 +0000
Merck’s (MRK) shares are up 11.7% this year so far on strong performance and positive regulatory updates on its PD-1 inhibitor Keytruda.

Be Sociable, Share!

Related Posts